µTASWako ™ i30
µTASWako TM i30 (Micro Total Analysis System) is the world’s only system for the automatic measurement of the biomarkers AFP-L3 and DCP.
Both markers, AFP-L3 (lectin-reactive alpha-fetoprotein) and DCP (des-gamma-carboxy prothrombin), are used to assess the risk of developing primary liver cell carcinoma (hepatocellular carcinoma, HCC).
µTASWako TM i30 integrates various immunoassay steps in microfluid microchips. Individual tests can be performed in just 9 minutes.